Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Patient Selection Services In Europe
6 services found
Manufactured by:Ariana Pharma based inParis, FRANCE
Thanks to our XAI KEM® platform we integrate extensive pre-clinical, clinical as well as Real World Evidence data, to define best dose, identify patient selection and surrogate endpoint biomarkers as well as alternative clinical indications. Our Precision Medicine clinical protocols allow for extensive data collection and use of stratification biomarkers, ...
Manufactured by:AB2 Bio Ltd. based inLausanne, SWITZERLAND
AB2 Bio has developed the first and proprietary assay to detect and measure free IL-18 in body fluids, which gives us the capability of identifying diseases associated with free IL-18 levels. The assay could also be used as a companion diagnostic to select patients most likely to respond to treatment with ...
Manufactured by:Berlin Heart GmbH based inBerlin, GERMANY
Support at all times: We support you individually in establishing your VAD program. In order to answer your questions about our products and the treatment of your patients, we are available for you anywhere in the world around the clock. Our team which has years of clinical experience is at your side at all times. Our goal is to assist you individually and at any time in the VAD therapy of your ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s Cancer Immune Atlas allows clinical researchers to maximize the value of the data generated through our Immunogram analysis platform. The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate biomarker maps, assess toxicity and drug response, stratify patients, and develop predictive ...
by:Clinisys, Inc. based inTucson, ARIZONA (USA)
Vein-to-vein blood transfusion management improving patient safety. Clinisys Blood Bank Management is a comprehensive and fully compliant Blood Bank solution with multi-facility inventory control, automation, and patient safety measures. Our solution enables you to manage blood products issued to patients in a hospital or centralised transfusion ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...